이식형 제세동기(ICD) 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 유형별, NYHA 분류별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Implantable Cardioverter Defibrillator Market, valued at USD 3.62 Billion in 2024, is projected to experience a CAGR of 6.53% to reach USD 5.29 Billion by 2030. An Implantable Cardioverter Defibrillator (ICD) is a medical device surgically placed to continuously monitor cardiac rhythm and deliver electrical therapy, such as defibrillation or pacing, to correct life-threatening arrhythmias and prevent sudden cardiac arrest. The global market's expansion is driven by the increasing prevalence of cardiovascular diseases, an aging population more susceptible to cardiac conditions, and technological advancements enhancing device efficiency and longevity.

Key Market Drivers

The increasing incidence of cardiovascular diseases and sudden cardiac arrest serves as a primary driver for the global implantable cardioverter defibrillator market. As populations age and lifestyles introduce new cardiac risk factors, the number of individuals susceptible to life-threatening arrhythmias requiring ICD therapy expands. These critical cardiac events necessitate effective interventions to prevent sudden cardiac death and improve patient outcomes.

Key Market Challenges

A primary challenging factor confronting the global implantable cardioverter defibrillator market is the considerable expenditure associated with both device implantation and subsequent long-term patient care. These substantial financial hurdles directly restrict patient access to necessary therapy, particularly within regions characterized by developing healthcare infrastructures. This limitation on accessibility translates into a slower adoption rate for implantable cardioverter defibrillators, thereby impeding the overall market expansion.

Key Market Trends

Artificial intelligence and machine learning are significantly impacting the Global Implantable Cardioverter Defibrillator Market by enhancing diagnostic precision and optimizing therapy. These technologies empower ICDs to analyze vast cardiac data for personalized treatment. The 2025 Scientific Statement from the European Heart Rhythm Association, Heart Rhythm Society, and ESC Working Group on E-Cardiology highlighted AI's potential in advanced arrhythmia detection and outcome prediction.

Key Market Players

• Abbott Laboratories Inc.
• Medtronic Plc
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• MicroPort Scientific Corporation
• LivaNova PLC

Report Scope:

In this report, the Global Implantable Cardioverter Defibrillator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Implantable Cardioverter Defibrillator Market, By Product:

• Transvenous Implantable Cardioverter Defibrillators
• Subcutaneous Implantable Cardioverter Defibrillators

Implantable Cardioverter Defibrillator Market, By Type:

• Single Chamber ICDs
• Dual Chamber ICDs
• Biventricular Devices

Implantable Cardioverter Defibrillator Market, By NYHA Class:

• NYHA Class II
• NYHA Class III

Implantable Cardioverter Defibrillator Market, By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Implantable Cardioverter Defibrillator Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Implantable Cardioverter Defibrillator Market.

Available Customizations:

Global Implantable Cardioverter Defibrillator Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Implantable Cardioverter Defibrillator Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators)
  • 5.2.2. By Type (Single Chamber ICDs, Dual Chamber ICDs, Biventricular Devices)
  • 5.2.3. By NYHA Class (NYHA Class II, NYHA Class III)
  • 5.2.4. By End-User (Hospitals, Ambulatory Surgical Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Implantable Cardioverter Defibrillator Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By NYHA Class
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Implantable Cardioverter Defibrillator Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By NYHA Class
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Implantable Cardioverter Defibrillator Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By NYHA Class
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Implantable Cardioverter Defibrillator Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By NYHA Class
      • 6.3.3.2.4. By End-User

7. Europe Implantable Cardioverter Defibrillator Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By NYHA Class
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By NYHA Class
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By NYHA Class
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By NYHA Class
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By NYHA Class
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By NYHA Class
      • 7.3.5.2.4. By End-User

8. Asia Pacific Implantable Cardioverter Defibrillator Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By NYHA Class
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By NYHA Class
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By NYHA Class
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By NYHA Class
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By NYHA Class
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By NYHA Class
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Implantable Cardioverter Defibrillator Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By NYHA Class
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Implantable Cardioverter Defibrillator Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By NYHA Class
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Implantable Cardioverter Defibrillator Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By NYHA Class
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Implantable Cardioverter Defibrillator Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By NYHA Class
      • 9.3.3.2.4. By End-User

10. South America Implantable Cardioverter Defibrillator Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By NYHA Class
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Implantable Cardioverter Defibrillator Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By NYHA Class
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Implantable Cardioverter Defibrillator Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By NYHA Class
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Implantable Cardioverter Defibrillator Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By NYHA Class
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Implantable Cardioverter Defibrillator Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic Plc
• 15.3. Biotronik SE & Co. KG
• 15.4. Boston Scientific Corporation
• 15.5. MicroPort Scientific Corporation
• 15.6. LivaNova PLC

16. Strategic Recommendations

17. About Us & Disclaimer